Legislators Urge HASC To OK Psychedelic Research Targeting PTSD Treatment
Date
5/25/2023 11:06:47 PM
(MENAFN- Investor Brand Network) A surge in psychedelic research in recent years has revealed something quite interesting: several psychedelic drugs are capable of
alleviating symptoms of mental disorders
with relatively few side effects. Dubbed the
psychedelic renaissance , this movement has seen dozens of researchers across the world focus their attention on determining the possible benefits of leveraging psychedelic therapies in mental health treatment.
Given that a large portion of the American population battles with mental illness every day and existing treatments aren't always effective, safe and...
read more>>
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates
psychedelicnewsbreaks
designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text“Groovy” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published:
Do you have questions or are you interested in working with PNW?
ask our editor
PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office
PsychedelicNewsWire is part of the
investorbrandnetwork .
MENAFN25052023000224011066ID1106319739
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.